Testing Topefilgrastim to prevent preeclampsia in high-risk pregnancy
Part of Women’s health & pregnancy clinical trials.
This study tests whether a medication called Topefilgrastim can help prevent preeclampsia in pregnant women at high risk. It is given as an injection during early pregnancy (weeks 11-13) and aims to reduce the chances of developing this serious condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are 11 to 13 weeks pregnant with one baby
- Your doctor has said you are at high risk for preeclampsia based on a blood test or risk score
- You do not have HIV, hepatitis B, hepatitis C, or syphilis
- You are not taking lithium or other medications that might interact with the study drug
- You are not allergic to the study drug or similar products
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This study is testing a new treatment strategy for women with preeclampsia, a serious pregnancy condition that causes high blood pressure. If you have preeclampsia or a normal pregnancy, you may be able to join to help find better treatments.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.